HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,562 | +119425.0% | 13,468 | +31.6% | 0.00% | – |
| Q1 2023 | $8 | -20.0% | 10,232 | -26.3% | 0.00% | – |
| Q4 2022 | $10 | -99.8% | 13,888 | +153.9% | 0.00% | – |
| Q3 2022 | $6,000 | -33.3% | 5,470 | +5.5% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 5,184 | +144.9% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 2,117 | -25.0% | 0.00% | – |
| Q4 2021 | $21,000 | -84.1% | 2,824 | -83.1% | 0.00% | -100.0% |
| Q3 2021 | $132,000 | +325.8% | 16,733 | +655.4% | 0.00% | +200.0% |
| Q2 2021 | $31,000 | +55.0% | 2,215 | +131.9% | 0.00% | – |
| Q1 2021 | $20,000 | -77.8% | 955 | -82.2% | 0.00% | -100.0% |
| Q4 2020 | $90,000 | -49.2% | 5,374 | -48.5% | 0.00% | +50.0% |
| Q3 2020 | $177,000 | +580.8% | 10,439 | +557.8% | 0.00% | +100.0% |
| Q2 2020 | $26,000 | 0.0% | 1,587 | -10.3% | 0.00% | -50.0% |
| Q4 2019 | $26,000 | 0.0% | 1,769 | -7.9% | 0.00% | 0.0% |
| Q3 2019 | $26,000 | +2500.0% | 1,920 | +3154.2% | 0.00% | – |
| Q1 2019 | $1,000 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |